Chronic lithium downregulates cyclooxygenase-2 activity and prostaglandin E(2) concentration in rat brain (Q28575972)

2

1 reference

31 January 2017

R. Seemann

3

1 reference

31 January 2017

T. A. Rosenberger

4

1 reference

31 January 2017

M. A. Contreras

5

1 reference

31 January 2017

S. I. Rapoport

6

1 reference

31 January 2017

M. C. Chang

Signal transduction pathways. Molecular targets for lithium's actions

7

1 reference

31 January 2017

language of work or name

English

0 references

publication date

1 January 2002

1 reference

31 January 2017

1 reference

31 January 2017

7

1 reference

31 January 2017

8

1 reference

31 January 2017

845–850

1 reference

31 January 2017

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001111

Anti-bipolar therapy: mechanism of action of lithium

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001111

Molecular targets of lithium action

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001111

Long term lithium treatment suppresses p53 and Bax expression but increases Bcl-2 expression. A prominent role in neuroprotection against excitotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001111

Receptor-mediated activation of phospholipase A2 and arachidonic acid release in signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001111

Prostaglandin synthase-1 and prostaglandin synthase-2 are coupled to distinct phospholipases for the generation of prostaglandin D2 in activated mast cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001111

Regulated formation of eicosanoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001111

Possible role of prostaglandin E1 in the affective disorders and in alcoholism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001111

Glycerophospholipids in brain: their metabolism, incorporation into membranes, functions, and involvement in neurological disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001111

Arachidonic acid as a bioactive molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001111

Lithium decreases turnover of arachidonate in several brain phospholipids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001111

Dynamics of docosahexaenoic acid metabolism in the central nervous system: lack of effect of chronic lithium treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001111

Chronic lithium treatment decreases brain phospholipase A2 activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001111

85 kDa cytosolic phospholipase A2 is a target for chronic lithium in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001111

Prostaglandin synthase 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001111

Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001111

COX-2, a synaptically induced enzyme, is expressed by excitatory neurons at postsynaptic sites in rat cerebral cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001111

Analysis of the effects of cyclooxygenase (COX)-1 and COX-2 in spinal nociceptive transmission using indomethacin, a non-selective COX inhibitor, and NS-398, a COX-2 selective inhibitor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001111

Urethane suppresses rat lung inducible cyclooxygenase and nitric oxide synthase mRNA levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001111

Involvement of reactive oxygen intermediates in cyclooxygenase-2 expression induced by interleukin-1, tumor necrosis factor-alpha, and lipopolysaccharide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001111

Inhibition of brain cyclooxygenase-2 activity and the antipyretic action of nimesulide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001111

Analysis of gene expression with cDNA microarrays in rat brain after 7 and 42 days of oral lithium administration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001111

Different intracellular locations for prostaglandin endoperoxide H synthase-1 and -2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001111

Cytosolic phospholipase A2 gene in human and rat: chromosomal localization and polymorphic markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001111

Chronic valproate treatment decreases the in vivo turnover of arachidonic acid in brain phospholipids: a possible common effect of mood stabilizers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001111

Cox-2-specific inhibitors: definition of a new therapeutic concept

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001111

Is aspirin, as used for antithrombosis, an emotion-modulating agent?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001111

Post-transcriptional control of cyclooxygenase-2 gene expression. The role of the 3'-untranslated region

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001111

Human cyclooxygenase-2 cDNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001111

Prostaglandin E(2) regulates the level and stability of cyclooxygenase-2 mRNA through activation of p38 mitogen-activated protein kinase in interleukin-1 beta-treated human synovial fibroblasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001111

Prostaglandin D2 and sleep--a molecular genetic approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001111

Molecular mechanisms of sleep-wake regulation: a role of prostaglandin D2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001111

Evidence that brain prostaglandin E2 is involved in physiological sleep-wake regulation in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001111

A biochemical basis for the actions of lithium on behaviour and on immunity: relapsing and remitting disorders of inflammation and immunity such as multiple sclerosis or recurrent herpes as manic-depression of the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001111

Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001111

Cross-national comparisons of seafood consumption and rates of bipolar disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001111

Docosahexaenoic acid is a strong inhibitor of prostaglandin but not leukotriene biosynthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001111

Inhibitory effects of omega-3 fatty acids on protein kinase C activity in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001111

Reversed-phase high-pressure liquid chromatography of arachidonic acid metabolites formed by cyclooxygenase and lipoxygenases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001111

Changes of vascular reactivity induced by low vasopressin concentrations: interactions with cortisol and lithium and possible involvement of prostaglandins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001111

7 January 2021

Cyclooxygenase-2 contributes to functional hyperemia in whisker-barrel cortex.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001111

7 January 2021

Treatment advances in bipolar disorder--making up for lost time

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001111

7 January 2021

The effects of valproate on the arachidonic acid metabolism of rat brain microvessels and of platelets

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001111

7 January 2021

Genetic association between alleles of pancreatic phospholipase A2 gene and bipolar affective disorder

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001111

7 January 2021

Mutational analysis of phospholipase A2A: a positional candidate susceptibility gene for bipolar disorder

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001111

7 January 2021

Prostaglandin E (EP) receptor subtypes and sleep: promotion by EP4 and inhibition by EP1/EP2

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001111

7 January 2021

Identifiers

DOI

10.1038/SJ.MP.4001111

1 reference

Consolidated OpenCitations Corpus – April 2017

Dimensions Publication ID

971041

1042851048

0 references

971041

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

1 reference